Showing results (61-70 of 141) with videos related to
Sort By:
Pageof 15
International Journal of Cancer|May 18, 1999
Influence of cell concentration in limiting the therapeutic benefit of P-glycoprotein reversal agentsJ K Tunggal, J R Ballinger, I F TannockThe Journal of Urology|November 17, 1998
High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapyP M Czaykowski, M J Moore, I F TannockBritish Journal of Cancer|July 17, 1998
The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenaseM Yamagata, K Hasuda, T Stamato, et al.Cancer Research|September 1, 1983
Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivoA M Rauth, J K Mohindra, I F TannockAnnals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publicationC De Bellefeuille, C A Morrison, I F TannockJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Bone metastases: pathophysiology and management policyO S Nielsen, A J Munro, I F TannockBritish Journal of Cancer|February 1, 1993
Therapeutic potential of analogues of amiloride: inhibition of the regulation of intracellular pH as a possible mechanism of tumour selective therapyR P Maidorn, E J Cragoe, I F TannockAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancerF Joly, J Vardy, M Pintilie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynxL L Siu, P M Czaykowski, I F TannockCancer Research|July 14, 1998
Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1beta-converting enzyme inhibitionB W Zanke, C Lee, S Arab, et al.Pageof 15